Erratum: MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog (Journal of Biological Chemistry (2012) 287 (34970–34978) DOI: 10.1074/jbc.M112.374611);MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog

Journal of Biological Chemistry

Volumn 287, Issue 42, 2012, Pages 34970-34978

  Xu, Cheng Xiong ^a   Xu, Meng ^a   Tan, Lei ^a   Yang, Hua ^a   Permuth Wey, Jennifer ^a   Kruk, Patricia A ^b   Wenham, Robert M ^a   Nicosia, Santo V ^a,b   Lancaster, Johnathan M ^a   Sellers, Thomas A ^a   Cheng, Jin Q ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; STEM CELLS;

CELL LINES; CHEMORESISTANCE; HUMAN MALIGNANCIES; OVARIAN CANCER CELLS; OVARIAN CANCERS; SELF RENEWAL; THERAPEUTIC TARGETS; WILD TYPES;

DISEASES;

ACTIN; MICRORNA 214; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL POPULATION; CELL RENEWAL; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; WILD TYPE;

EID: 84867417506     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/JBC.A112.374611     Document Type: Erratum

References (45)

1. Bartel, D. P. (2009) MicroRNAs. Target recognition and regulatory functions. Cell 136, 215-233
2. Yang, H., Kong, W., He, L., Zhao, J. J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., and Cheng, J. Q. (2008) MicroRNA expression profiling in human ovarian cancer. MiR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433 (Pubitemid 351380068)
3. Ueda, T., Volinia, S., Okumura, H., Shimizu, M., Taccioli, C., Rossi, S., Alder, H., Liu, C. G., Oue, N., Yasui, W., Yoshida, K., Sasaki, H., Nomura, S., Seto, Y., Kaminishi, M., Calin, G. A., and Croce, C. M. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer. A microRNA expression analysis. Lancet Oncol. 11, 136-146
4. Qiang, R., Wang, F., Shi, L. Y., Liu, M., Chen, S., Wan, H. Y., Li, Y. X., Li, X., Gao, S. Y., Sun, B. C., and Tang, H. (2011) Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int. J. Biochem. Cell Biol. 43, 632-641
5. Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella-Abate, S., De Pittà, C., Pinatel, E., Stadler, M. B., Provero, P., Bernengo, M. G., Osman, I., and Taverna, D. (2011) MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 30, 1990-2007
6. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C., and Croce, C. M. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103, 2257-2261 (Pubitemid 43271657)
7. Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S. F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., Tavaré, S., Caldas, C., and Miska, E. A. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8, R214
8. Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., and Cole, C. N. (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 67, 11612-11620
9. Nguyen, L. V., Vanner, R., Dirks, P., and Eaves, C. J. (2012) Cancer stem cells. An evolving concept. Nat. Rev. Cancer 12, 133-143
10. Liu, C., and Tang, D. G. (2011) MicroRNA regulation of cancer stem cells. Cancer Res. 71, 5950-5954
11. Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., Dirbas, F. M., Somlo, G., Pera, R. A., Lao, K., and Clarke, M. F. (2009) Down-regulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603
12. Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., Desano, J. T., Bommer, G. T., Fan, D., Fearon, E. R., Lawrence, T. S., and Xu, L. (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 4, e6816
13. Tay, Y., Zhang, J., Thomson, A. M., Lim, B., and Rigoutsos, I. (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124 -1128
14. Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., and Weinberg, R. A. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507 (Pubitemid 351601215)
15. Jeter, C. R., Liu, B., Liu, X., Chen, X., Liu, C., Calhoun-Davis, T., Repass, J., Zaehres, H., Shen, J. J., and Tang, D. G. (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30, 3833-3845
16. Leis, O., Eguiara, A., Lopez-Arribillaga, E., Alberdi, M. J., Hernandez-Garcia, S., Elorriaga, K., Pandiella, A., Rezola, R., and Martin, A. G. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31, 1354-1365
17. Kashyap, V., Rezende, N. C., Scotland, K. B., Shaffer, S. M., Persson, J. L., Gudas, L. J., and Mongan, N. P. (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 18, 1093-1108
18. Liu, Q., Kaneko, S., Yang, L., Feldman, R. I., Nicosia, S. V., Chen, J., and Cheng, J. Q. (2004) Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J. Biol. Chem. 279, 52175-52182 (Pubitemid 39656591)
19. Deng, S., Yang, X., Lassus, H., Liang, S., Kaur, S., Ye, Q., Li, C., Wang, L. P., Roby, K. F., Orsulic, S., Connolly, D. C., Zhang, Y., Montone, K., Bützow, R., Coukos, G., and Zhang, L. (2010) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 5, e10277
20. McLean, K., Gong, Y., Choi, Y., Deng, N., Yang, K., Bai, S., Cabrera, L., Keller, E., McCauley, L., Cho, K. R., and Buckanovich, R. J. (2011) Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J. Clin. Invest. 121, 3206-3219
21. Yang, X., Lin, X., Zhong, X., Kaur, S., Li, N., Liang, S., Lassus, H., Wang, L., Katsaros, D., Montone, K., Zhao, X., Zhang, Y., Bützow, R., Coukos, G., and Zhang, L. (2010) Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res. 70, 9463-9472
22. Monteiro, J., and Fodde, R. (2010) Cancer stemness and metastasis. Therapeutic consequences and perspectives. Eur. J. Cancer 46, 1198-1203
23. Moon, J. H., Heo, J. S., Kim, J. S., Jun, E. K., Lee, J. H., Kim, A., Kim, J., Whang, K. Y., Kang, Y. K., Yeo, S., Lim, H. J., Han, D. W., Kim, D. W., Oh, S., Yoon, B. S., Schöler, H. R., and You, S. (2011) Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res. 21, 1305-1315
24. Esquela-Kerscher, A., and Slack, F. J. (2006) Oncomirs. MicroRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269
25. Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., and Xu, Y. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171 (Pubitemid 40268131)
26. Pan, G., and Thomson, J. A. (2007) Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 17, 42-49 (Pubitemid 46096423)
27. De Feudis, P., Debernardis, D., Beccaglia, P., Valenti, M., Graniela Siré, E., Arzani, D., Stanzione, S., Parodi, S., D'Incalci, M., Russo, P., and Broggini, M. (1997) DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br. J. Cancer 76, 474-479 (Pubitemid 27331212)
28. 2/M arrest of human ovarian cancer cells. Anticancer Res. 27, 3927-3934
29. Hagopian, G. S., Mills, G. B., Khokhar, A. R., Bast, R. C., Jr., and Siddik, Z. H. (1999) Expression of p53 in cisplatin-resistant ovarian cancer cell lines. Modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Clin. Cancer Res. 5, 655-663 (Pubitemid 29131977)
30. Tan, L., Sui, X., Deng, H., and Ding, M. (2011) Holoclone forming cells from pancreatic cancer cells enrich tumor-initiating cells and represent a novel model for study of cancer stem cells. PLoS ONE 6, e23383
31. Yin, G., Chen, R., Alvero, A. B., Fu, H. H., Holmberg, J., Glackin, C., Rutherford, T., and Mor, G. (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29, 3545-3553
32. Kryczek, I., Liu, S., Roh, M., Vatan, L., Szeliga, W., Wei, S., Banerjee, M., Mao, Y., Kotarski, J., Wicha, M. S., Liu, R., and Zou, W. (2012) Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int. J. Cancer 130, 29-39
33. Dylla, S. J., Beviglia, L., Park, I. K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., Clarke, M. F., Hoey, T., Lewicki, J., and Gurney, A. L. (2008) Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoSONE 3, e2428
34. Tanei, T., Morimoto, K., Shimazu, K., Kim, S. J., Tanji, Y., Taguchi, T., Tamaki, Y., and Noguchi, S. (2009) Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 15, 4234-4241
35. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., and Yamanaka, S. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135
36. Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., and Izpisúa Belmonte, J. C. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144
37. Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., and Serrano, M. (2009) The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136-1139
38. Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., and Blasco, M. A. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153
39. Liu, Y., Elf, S. E., Asai, T., Miyata, Y., Liu, Y., Sashida, G., Huang, G., Di Giandomenico, S., Koff, A., and Nimer, S. D. (2009) The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle 8, 3120-3124
40. Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., and Pelicci, P. G. (2009) The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095
41. Liu, Y., Elf, S. E., Miyata, Y., Sashida, G., Liu, Y., Huang, G., Di Giandomenico, S., Lee, J. M., Deblasio, A., Menendez, S., Antipin, J., Reva, B., Koff, A., and Nimer, S. D. (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4, 37-48
42. Herrera-Merchan, A., Cerrato, C., Luengo, G., Dominguez, O., Piris, M. A., Serrano, M., and Gonzalez, S. (2010) MiR-33-mediated down-regulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 9, 3277-3285
43. Soussi, T., Béroud, C. (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer 1, 233-240 (Pubitemid 33741898)
44. Flynt, A. S., Li, N., Thatcher, E. J., Solnica-Krezel, L., Patton, J. G. (2007) Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat. Genet. 39, 259-263 (Pubitemid 46184359)
45. Li, N., Flynt, A. S., Kim, H. R., Solnica-Krezel, L., Patton, J. G. (2008) Dispatched Homolog 2 is targeted by miR-214 through a combination of three weak microRNA recognition sites. Nucleic Acids Res. 36, 4277-4485